Abstract:Objective::To evaluate the efficacy of 0.1% Tacrolimus eye drops in the treatment of dry eye (DE) caused by chronic graft-versus-host disease (cGVHD-DE) and compare it with the treatment of lubricating eye drops.Methods::Prospective clinical study. The chronic graft-versus-host disease (cGVHD) patients with DE from the First Affiliated Hospital, Zhejiang University School of Medicine were included according to the inclusion criteria and categorized randomly into two different groups, Tacrolimus group (TAC) and sodium hyaluronate group (SH). Data were collected at the baseline, 2 weeks and 2 months after the treatments on patients' age, gender, primary diagnosis, time of onset, visual acuity (VA), ocular surface disease index (OSDI), corneal fluorescein staining (FL) and Schirm Ⅰ test (SⅠt). Other four objective DE indicators, including the height of tear meniscus (TMH), the first non-invasive tear break-up time (NIBUTf), the degree of conjunctival injection and the infrared meibography were also obtained and recorded by Keratograph 5M. Data were analyzed by variance analysis, Firedman and t-test, etc. Results::A total of 21 patients with 42 eyes were included, 11 patients (22 eyes) in the TAC, 10 patients (20 eyes) in SH. There was no significant difference in age, gender, and all clinical indicators at the baseline between the two groups. 2 weeks after the treatments, in TAC group, OSDI score ( t=3.99, P=0.003), NIBUTf in both eyes (right eye: t=2.30, P=0.044; left eye: t=2.42, P=0.034) were significantly improved when compared with the baseline, in SH group, the indicators were OSDI score ( t=3.20, P=0.011) and NIBUTf in right eyes ( t=2.46, P=0.036) that had significant improvement. After 2 months of treatment, all clinical dry eye indicators in the TAC group were significantly improved compared with the baseline ( P<0.05). But in the SH group, the SⅠt and the infrared meibography had no statistically significant difference when compared with the baseline. Comparing the two groups after 2 months of treatment, we found that all indicators in the TAC group were more significantly improved than that in the SH group, except for the FL, in which the difference had no statistical significance ( P<0.05). No adverse ocular effect was found in the study in both groups. Conclusions::0.1% tacrolimus eye drops are safe and effective in the treatment of cGVHD-DE, and Keratograph 5M is helpful in the evaluation and follow-up of the treatments.

Clinical Study of Glutathione Eye Drop

Randomized Controlled Study of The Anti-Cataract of Glutathione Ophthalmic Solution Compared with Neuthione in Patients with Senile Cataract

The treatment effectiveness of local application of glucocorticoid for meibomian gland dysfunction related dry eye

Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial

The Effect of Intense Pulsed Light Combined with Topical 0.05% Cyclosporin a Eyedrops in the Treatment of Sjögren’s Syndrome Related Dry Eye

Evaluation of 0.1% Tacrolimus Eye Drops in the Treatment of Dry Eye Patients Caused by Chronic Graft-Versus-Host Disease

Clinical Study on Thyroid-associated Immune Exophthalmos Treated by compound anisodine Combined with Shihu Xiaolei Pills

TREATMENT OF DEGENERATIVE CHANGES IN THE EPITHELIUM OF THE OCULAR SURFACE WITH "DRY EYE" SYNDROME

Evaluation of Two Artificial Tears Containing Hyaluronic Acid for Post Cataract Surgery Dry Eye Disease: A Randomized Controlled Trial

Oral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study

Efficacy and Safety of 0.05% Cyclosporine Ophthalmic Emulsion in Treatment of Chinese Patients with Moderate to Severe Dry Eye Disease: A 12-Week, Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase III Clinical Study

Changes of the bulbar conjunctiva as the result of glaucoma medication treatment

Clinical Efficacy and Safety of Compound Gentamicin Diclofenac Sodium Eyedrops on Postoperative Inflammation of Phacoemulsification and Trabeculectomy

Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water

Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome

Two – Arm, Randomized, Open Labeled, Comparative, Prospective Clinical Study to Assess the Efficacy of Amalaki Ghrita Aashchyotana versus Hydroxypropyl Methylcellulose Eye Ointment in Dry Eye Syndrome with special reference to Shushkaakshipaka

[The clinical efficacy and safety study of Esculin and Digitalis glycosides Eye Drops in treating ametropic asthenopia]

Evaluation of Dry Eye Treatment with Sodium Hyaluronate- and Dexpanthenol-Containing Eye Drops on Ocular Surface Improvement after Cataract Surgery

A clinical study of topical treatment for thyroid-associated ophthalmopathy with dry eye syndrome

Pharmacokinetics and Relative Bioavailability of Glutathione Tablets

Evaluation of cyclosporine 0.05% and artificial tears for the management of dry eye disease following cataract surgery: a randomized controlled trial